Solventum Corporation
HealthcareNYSE:SOLV · New York Stock Exchange
-$1.12 today
Vol 1.12M · Avg 1.77M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
30.8%
avg 13.7%
ROIC
17.8%
avg 9.7%
ROA
10.9%
avg 7.4%
Analysis
ROE is currently the strongest return metric at 30.8% versus its period average of 13.7%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Bryan C. Hanson | Chief Executive Officer & Director | $4.93M | — | 59 | $158,225.00 | 0.09% |
Heather L. Knight | Chief Commercial Officer | $2.26M | — | 54 | $3,300.00 | <0.01% |
Wayde D. McMillan | Executive VP & CFO | $1.97M | — | 56 | $3,300.00 | <0.01% |
Amy Landucci | Chief Information & Digital Officer | $1.66M | — | 51 | $3,300.00 | <0.01% |
Marcela A. Kirberger | Chief Corporate & Legal Affairs Officer & Corporate Secretary | $1.60M | — | 59 | $15,492.00 | <0.01% |
Tammy L. Gomez | Chief Human Resources Officer | $1.12M | — | 53 | $3,300.00 | <0.01% |
Rachel H. Ellingson | Chief Strategy & Corporate Development Officer | — | — | 56 | — | — |
Mike Spears | Senior Vice President of Regulatory Affairs & Quality Assurance | — | — | — | — | — |
Paul S. Harrington | Chief Supply Chain Officer | — | — | 56 | $22,130.00 | 0.01% |
Amy Wakeham | Senior Vice President of Investor Relations & External Finance Communications | — | — | — | $3,300.00 | <0.01% |
Garri Garrison | President of Health Information Systems | — | — | 66 | — | — |
Kate Dobbs | Chief Communications & Corporate Marketing Officer | — | — | — | — | — |
Mary T. Wilcox | Senior Vice President, Corporate Controller & Chief Accounting Officer | — | — | 61 | $7,632.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$100,344.25
Sells
1
$646.36M
Net Sentiment
$646.26M
Net selling
Most Active
Wendell Amy McBride
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Wendell Amy McBride Direct | Buy | 1.5K | $68.03 | $100,344.25 | |
| Aug 15, 2025 | 3M CO Direct | Sell | 8.80M | $73.45 | $646,360,000.00 |
Analysis
Insiders reported 1 buys worth $100,344.25 and 1 sells worth $646.36M over the last 12 months. That adds up to net selling of $646.26M. Wendell Amy McBride was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -31.2% | +25.3% (6yr)2 analysts |
| Revenue | N/A | N/A | +0.3% | +2.5% (6yr)5 analysts |
| Net Income | N/A | N/A | -31.0% | +25.5% (6yr)5 analysts |
| EBIT | N/A | N/A | -18.0% | +10.9% (6yr)5 analysts |
Analysis
Recent growth has been strongest in Revenue at +0.3% over three years. Forward estimates point to Net Income at +25.5% (6yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Align Technology, Inc.
NASDAQ:ALGN
$12.50B
Elanco Animal Health Incorporated
NYSE:ELAN
$12.09B
ICON Public Limited Company
NASDAQ:ICLR
$11.14B
Dr. Reddy's Laboratories Limited
NYSE:RDY
$11.12B
Revvity, Inc.
NYSE:RVTY
$11.12B
Encompass Health Corporation
NYSE:EHC
$10.06B
Universal Health Services, Inc.
NYSE:UHS
$9.19B
The Ensign Group, Inc.
NASDAQ:ENSG
$8.68B
Qiagen N.V.
NYSE:QGEN
$7.65B
Doximity, Inc.
NYSE:DOCS
$3.76B
Who manages SOLV?
Solventum Corporation (SOLV) lists 13 active executives. The top listed executive is Rachel H. Ellingson, Chief Strategy & Corporate Development Officer.
Are SOLV insiders buying or selling?
Recent insider activity shows net selling of $656.97M.
Explore More
Continue the stock analysis
Jump to another research area for this company.